StockData
VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31

VITASPRING BIOMEDICAL CO. LTD.

Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 17, 2026
$0.03+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$6.58M
P/E (TTM)
–
Dividend yield
–

Community

Notes and questions about Vitaspring Biomedical from other investors

No posts about VSBC yet

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.